Zolmitriptan structure
|
Common Name | Zolmitriptan | ||
---|---|---|---|---|
CAS Number | 139264-17-8 | Molecular Weight | 287.357 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 563.3±38.0 °C at 760 mmHg | |
Molecular Formula | C16H21N3O2 | Melting Point | 136-141ºC | |
MSDS | Chinese USA | Flash Point | 294.5±26.8 °C |
Name | zolmitriptan |
---|---|
Synonym | More Synonyms |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 563.3±38.0 °C at 760 mmHg |
Melting Point | 136-141ºC |
Molecular Formula | C16H21N3O2 |
Molecular Weight | 287.357 |
Flash Point | 294.5±26.8 °C |
Exact Mass | 287.163391 |
PSA | 57.36000 |
LogP | 1.64 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.620 |
Storage condition | Refrigerator |
Hazard Codes | Xi: Irritant; |
---|---|
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | NONH for all modes of transport |
RTECS | RQ2707000 |
HS Code | 2934999090 |
~87% Zolmitriptan CAS#:139264-17-8 |
Literature: LABORATORIOS VITA, S. A. Patent: WO2004/14901 A1, 2004 ; Location in patent: Page 18-19 ; |
~% Zolmitriptan CAS#:139264-17-8 |
Literature: WO2009/44211 A1, ; Page/Page column 17; 22-23 ; |
~74% Zolmitriptan CAS#:139264-17-8 |
Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column title page; 9-10; Figure 1 ; |
~74% Zolmitriptan CAS#:139264-17-8 |
Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column 8 ; |
~46% Zolmitriptan CAS#:139264-17-8 |
Literature: Aminul, Islam; Chandan, Bhar; Sahadev, Katam Patent: US2005/245585 A1, 2005 ; Location in patent: Page/Page column 8-9 ; |
~% Zolmitriptan CAS#:139264-17-8 |
Literature: WO2008/104134 A2, ; Page/Page column title page; 5-7 ; |
~% Zolmitriptan CAS#:139264-17-8 |
Literature: WO2008/104135 A1, ; Page/Page column 5 ; |
~% Zolmitriptan CAS#:139264-17-8 |
Literature: US2011/112157 A1, ; |
~% Zolmitriptan CAS#:139264-17-8 |
Literature: WO2008/104135 A1, ; Page/Page column 4 ; |
Precursor 8 | |
---|---|
DownStream 1 | |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.
Eur. J. Pharm. Biopharm. 94 , 386-92, (2015) Formulation of sublingual tablets of drugs with limited permeability poses a great challenge due to their poor absorption. In this study, bioenhanced sublingual tablets (BESTs) of zolmitriptan were pr... |
|
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
PLoS ONE 8(1) , e52683, (2013) Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure ... |
|
Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.
Drug Dev. Ind. Pharm. 37(12) , 1509-16, (2011) Submicron emulsion was prepared for rapid and effective nasal absorption of zolmitriptan (ZT). The different charge inducers and pH values of the formulations were evaluated to optimize the formulatio... |
2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)- |
BW 311C90 |
(S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone |
Zomigoro |
(4S)-4-({3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one |
Zolmitriptan |
Zomigon |
(4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one |
(S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine |
AscoTop |
Zomig |
MFCD00871503 |